BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following the Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.
Thought its participation in several partnerships, R&D&I projects and related calls, Keralty group works in the implementation of attention models, management models and health technologies and tools. In this way, Keralty aims to create competitive advantage that will allow the group share and add value to its patients and health professionals.
Biokeralty organizes the six-month follow-up meeting of the European TEN4CARE project in Bilbao Biokeralty Research Institute hosted the second plenary meeting of the TEN4CARE consortium, a strategic initiative funded by the Horizon Europe program that seeks to revolutionize tendon repair through regenerative…
The IN-ARMOR project registers a new patent on novel immune system inducers The consortium of the IN-ARMOR project, funded by European Union´s Horizon Europe research and innovation programme under grant agreement No 101080889, has registered a new patent titled “Novel small molecules…
For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.
Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.
Primary care
Cancer
Chronic and neurodegenerative
Infectious diseases
E-health
Genomics and personalized
Regenerative medicine
Nanotechnology
Education
Community
Social
Health value